NEW YORK, April 2 -- The American Journal of Respiratory Cell and Molecular Biology, a journal from the American Thoracic Society that says it focuses on pulmonary biology, published research articles on the following topics in its April 2024 edition (Vol. 70, Issue 4):

Editorials:

* Getting the Timing Right: Controlling BCL-2 Inhibition as an Antifibrotic Therapy

* Alveolar Epithelial Cell Dysfunction in Idiopathic Pulmonary Fibrosis Linked to Lipid Alter . . .

Click here for more information about our products